IRCT20190210042676N16招募中2 期
Evaluation of safety and the effectiveness of Bioba (Prime) anti-hair loss line (serum and shampoo) in reducing diffuse and scattered hair loss and Improving hair volume and density
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 19
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- All
入选标准
- •Male or female aged 18-55 years
- •Diffuse and scattered hair loss (Count at least 300 hairs in a combing test over three days)
- •General health
- •Voluntary participation and signing written informed consent
排除标准
- •Chronic active scalp disease other than hair loss
- •Using any prescribed drug or OTC for hair loss within the past 3 months
- •Any severe weight loss or strict diet therapy during the study
- •Pregnancy or breastfeeding
研究者
相似试验
已完成
不适用
Evaluation of the safety and efficacy of the BioWeld1 system in the treatment of acne vulgarisACNE VULGARISL70.0Acne vulgarisDRKS00025008IonMed Ltd.34
尚未招募
1 期
Evaluation of the effectiveness and safety of bianshi moxibustion infrared dry eye therapeutic instrument in the treatment of meibomian gland dysfunctiomeibomian gland dysfunctionITMCTR1900002769Peking University Third Hospital
招募中
4 期
The study to evaluate the efficacy and safety of Bipolar Radiofrequency-Assisted Lipolysis for Facial ContouringHealthy patientBipolar Radiofrequency-Assisted Lipolysis, Facial ContouringTCTR20230516008ASTRACO MEDICAL NETWORKS LTD.39
招募中
4 期
The study to evaluate the efficacy and safety of Bipolar Radiofrequency-Assisted Lipolysis for cheek and nasolabial fold ContouringHealthy patientBipolar Radiofrequency-Assisted Lipolysis, Cheek and nasolabial fold ContouringTCTR20230515001ASTRACO MEDICAL NETWORKS LTD.39
招募中
4 期
The study to evaluate the efficacy and safety of Bipolar Radiofrequency-Assisted Lipolysis combined with Adjustable-depth fractional microneedle bipolar radiofrequency for periorbital RejuvenatioHealthy PatientBipolar Radiofrequency-Assisted Lipolysis,Adjustable-depth fractional microneedle bipolar radiofrequency,periorbital RejuvenationTCTR20230417001ASTRACO MEDICAL NETWORKS LTD.38